Vitro Biopharma, Inc. Quarterly Liabilities in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Vitro Biopharma, Inc. quarterly Liabilities history and growth rate from Q3 2010 to Q2 2024.
  • Vitro Biopharma, Inc. Liabilities for the quarter ending July 31, 2024 was $14.1M, a 62% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14.1M +$5.41M +62% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $14.7M +$7.38M +102% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $12.2M +$5.99M +96.6% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $9.43M +$3.7M +64.4% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 $8.72M Jul 31, 2023 10-Q 2023-08-28
Q1 2023 $7.27M Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $6.2M Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $5.74M Oct 31, 2022 10-K 2024-01-29
Q3 2015 $2.5M +$232K +10.3% Oct 31, 2015 10-K 2016-09-22
Q2 2015 $2.44M +$235K +10.6% Jul 31, 2015 10-Q 2016-03-30
Q1 2015 $2.39M +$208K +9.54% Apr 30, 2015 10-Q 2016-01-22
Q4 2014 $2.31M +$180K +8.48% Jan 31, 2015 10-Q 2015-03-24
Q3 2014 $2.27M +$256K +12.7% Oct 31, 2014 10-K 2016-09-22
Q2 2014 $2.21M Jul 31, 2014 10-Q 2014-09-22
Q1 2014 $2.18M Apr 30, 2014 10-Q 2014-06-19
Q4 2013 $2.13M Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $2.01M Oct 31, 2013 10-K 2015-02-13
Q3 2011 $1.65M -$49.2K -2.89% Oct 31, 2011 10-K/A 2012-02-16
Q2 2011 $1.61M Jul 31, 2011 10-Q/A 2011-10-12
Q3 2010 $1.7M Oct 31, 2010 10-K/A 2012-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.